Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVAX + Androgen Ablation in Biochemically Relapsed Prostate Cancer
NCT00771017Phase 2Withdrawn
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jul 2008
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of GVAX pancreatic cancer vaccine in prostate cancer (PCa), sponsored by Eastern Cooperative Oncology Group. Planned start Jul 2008; status: withdrawn.
02
Drugs
GVAX pancreatic cancer vaccine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00771017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771017.